Antimicrobial resistance (AMR) has been an ongoing topic in public health circles for years. Superbugs like methicillin-resistant Staphylococcus aureus, or MRSA, are often discussed in the context of healthcare settings or outbreaks in first-world countries like the U.S.
But a new article in The Lancet has found that the extent of AMR, especially in low and middle-income countries, may be higher than we thought. This episode was hosted by Diane Bao.